{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:46:27Z","timestamp":1786988787035,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy Research"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.eplepsyres.2025.107569","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T11:52:21Z","timestamp":1745581941000},"page":"107569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Adequate and inadequate dosing of anti-seizure medications in status epilepticus"],"prefix":"10.1016","volume":"214","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-2726-696X","authenticated-orcid":false,"given":"Susan","family":"Schrader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"14","key":"10.1016\/j.eplepsyres.2025.107569_bib1","doi-asserted-by":"crossref","first-page":"3028","DOI":"10.3390\/jcm10143028","article-title":"Review and updates on the treatment of refractory and super refractory status epilepticus","volume":"10","author":"Alolayan","year":"2021","journal-title":"J. Clin. Med"},{"key":"10.1016\/j.eplepsyres.2025.107569_bib2","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.2147\/IJGM.S295855","article-title":"Epidemiology and outcomes of status epilepticus","volume":"14","author":"Ascoli","year":"2021","journal-title":"Int J. Gen. Med"},{"key":"10.1016\/j.eplepsyres.2025.107569_bib3","article-title":"Suboptimal dosing of benzodiazepines and levetiracetam in a cohort of status epilepticus patients and outcomes associated with inadequate dosing [published online ahead of print, 2022 Apr 10]","author":"Braun","year":"2022","journal-title":"J. Pharm. Pr."},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107569_bib4","doi-asserted-by":"crossref","first-page":"48","DOI":"10.5698\/1535-7597-16.1.48","article-title":"Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the guideline committee of the american epilepsy society","volume":"16","author":"Glauser","year":"2016","journal-title":"Epilepsy Curr."},{"issue":"22","key":"10.1016\/j.eplepsyres.2025.107569_bib5","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1905795","article-title":"Randomized trial of three anticonvulsant medications for status epilepticus","volume":"381","author":"Kapur","year":"2019","journal-title":"N. Engl. J. Med"},{"issue":"1","key":"10.1016\/j.eplepsyres.2025.107569_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3988\/jcn.2021.17.1.11","article-title":"Antiepileptic drug therapy for status epilepticus","volume":"17","author":"Kim","year":"2021","journal-title":"J. Clin. Neurol."},{"key":"10.1016\/j.eplepsyres.2025.107569_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107459","article-title":"Epidemiology of status epilepticus in the United States: a systematic review","volume":"112","author":"Lu","year":"2020","journal-title":"Epilepsy Behav."},{"issue":"4","key":"10.1016\/j.eplepsyres.2025.107569_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1684\/epd.2018.0987","article-title":"Inadequate benzodiazepine dosing may result in progression to refractory and non-convulsive status epilepticus","volume":"20","author":"Rao","year":"2018","journal-title":"Epileptic Disord."},{"issue":"8","key":"10.1016\/j.eplepsyres.2025.107569_bib9","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1111\/acem.13811","article-title":"Underdosing of benzodiazepines in patients with status epilepticus enrolled in established status epilepticus treatment trial","volume":"26","author":"Sathe","year":"2019","journal-title":"Acad. Emerg. Med"},{"issue":"3","key":"10.1016\/j.eplepsyres.2025.107569_bib10","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/epi.16825","article-title":"Patterns of benzodiazepine underdosing in the Established Status Epilepticus Treatment Trial","volume":"62","author":"Sathe","year":"2021","journal-title":"Epilepsia"}],"container-title":["Epilepsy Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125000701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920121125000701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T05:04:39Z","timestamp":1749099879000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920121125000701"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":10,"alternative-id":["S0920121125000701"],"URL":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107569","relation":{},"ISSN":["0920-1211"],"issn-type":[{"value":"0920-1211","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adequate and inadequate dosing of anti-seizure medications in status epilepticus","name":"articletitle","label":"Article Title"},{"value":"Epilepsy Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eplepsyres.2025.107569","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107569"}}